Drug target could block brain inflammation linked to Alzheimer’s and Parkinson’s
Blocking a receptor called P2X7 significantly reduced inflammation in human brain tissue, revealing a potential new treatment strategy for neurological and psychiatric disorders. The discovery could help researchers repurpose existing drugs for conditions including traumatic brain injury, Alzheimer’s, Parkinson’s, depression, and schizophrenia.
We haven't written up this one. ScienceDaily has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- Drug target could block brain inflammation linked to Alzheimer’s and Parkinson’s sciencedaily.com
- A Takeda spinout builds case for its Parkinson’s drug biopharmadive.com
